| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMODIUM EXPRESS 2 mg | LOPERAMIDUM | COMPR. ORODISPERSABILE | A07DA03 | W71045002 | MCNEIL HEALTHCARE (IRELAND) LIMITED - IRLANDA | ||||||
| IMODIUM EXPRESS 2 mg | LOPERAMIDUM | COMPR. ORODISPERSABILE | A07DA03 | W71045003 | MCNEIL HEALTHCARE (IRELAND) LIMITED - IRLANDA | ||||||
| IMODIUM EXPRESS 2 mg | LOPERAMIDUM | COMPR. ORODISPERSABILE | A07DA03 | W71045004 | MCNEIL HEALTHCARE (IRELAND) LIMITED - IRLANDA | ||||||
| IMODIUM 2 mg | LOPERAMIDUM | CAPS. | A07DA03 | W64913001 | MCNEIL HEALTHCARE (IRELAND) LIMITED - IRLANDA | ||||||
| IMODIUM 2 mg | LOPERAMIDUM | CAPS. | A07DA03 | W64913002 | MCNEIL HEALTHCARE (IRELAND) LIMITED - IRLANDA | ||||||
| IMNOVID 4 mg | POMALIDOMIDUM | CAPS. | L04AX06 | W68143001 | BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA | X | |||||
| IMNOVID 3 mg | POMALIDOMIDUM | CAPS. | L04AX06 | W68142001 | BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA | X | |||||
| IMNOVID 2 mg | POMALIDOMIDUM | CAPS. | L04AX06 | W68141001 | BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA | X | |||||
| IMNOVID 1 mg | POMALIDOMIDUM | CAPS. | L04AX06 | W68140001 | BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA | X | |||||
| IMMUNINE 600 UI | FACTOR IX DE COAGULARE | PULB.+SOLV. PT. SOL. INJ./PERF. | B02BD04 | W62889001 | BAXALTA INNOVATIONS GMBH - AUSTRIA | ||||||
| IMMUNINE 1200 UI | FACTOR IX DE COAGULARE | PULB.+SOLV. PT. SOL. INJ./PERF. | B02BD04 | W62890001 | BAXALTA INNOVATIONS GMBH - AUSTRIA | ||||||
| IMMUNATE 500 UI FVIII/375 UI FVW | FACTOR VIII DE COAGULARE SI FACTOR VON WILLEBRAND | PULB.+SOLV. PT. SOL. INJ. | B02BD06 | W62887001 | BAXALTA INNOVATIONS GMBH - AUSTRIA | ||||||
| IMMUNATE 250 UI FVIII/190 UI FVW | FACTOR VIII DE COAGULARE SI FACTOR VON WILLEBRAND | PULB.+SOLV. PT. SOL. INJ. | B02BD06 | W62886001 | BAXALTA INNOVATIONS GMBH - AUSTRIA | ||||||
| IMMUNATE 1000 UI FVIII/750 UI FVW | FACTOR VIII DE COAGULARE SI FACTOR VON WILLEBRAND | PULB.+SOLV. PT. SOL. INJ. | B02BD06 | W62888001 | BAXALTA INNOVATIONS GMBH - AUSTRIA | ||||||
| IMJUDO 20 mg/ml | TREMELIMUMABUM | CONC. PT. SOL. PERF. | L01FX20 | W69596001 | ASTRAZENECA AB - SUEDIA | X | |||||
| IMJUDO 20 mg/ml | TREMELIMUMABUM | CONC. PT. SOL. PERF. | L01FX20 | W69596002 | ASTRAZENECA AB - SUEDIA | X | |||||
| IMIPENEM/CILASTATINA KABI 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W54532001 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| IMIPENEM/CILASTATINA KABI 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W54532002 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| IMIPENEM/CILASTATIN STERISCIENCE 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W70365001 | STERISCIENCE B.V. - TARILE DE JOS | ||||||
| IMIPENEM/CILASTATIN STERISCIENCE 500 mg/500 mg | IMIPENEMUM+CILASTATINUM | PULB. PT. SOL. PERF. | J01DH51 | W70365002 | STERISCIENCE B.V. - TARILE DE JOS |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman